Analysis of Nitrosamine Impurities in Pharmaceuticals
What you will learn
Understand what mutagenic impurities are and why it’s important to characterize and quantify them, even when present in trace amounts.
Understand the current regulatory guidelines for nitrosamines analysis in drug substance and product in Angiotensin II Receptor Blockers (sartan), ranitidine and metformin drugs
Learn about approaches for the prevention of the formation of GTIs and the confident identification and quantification of nitrosamines in APIs and drugs
